(Q51435193)
Statements
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment. (English)
1 reference
1 reference
P E Postmus
1 reference
A Becker
1 reference
L Crombag
1 reference
D A M Heideman
1 reference
A W van Wijk
1 reference
E F Smit
1 reference
23 July 2011
1 reference
47
1 reference
17
1 reference
2603-2606
1 reference